GW Pharmaceuticals Other Liabilities

GW Pharmaceuticals (GWPH) currently reports a other liabilities of $2.2M as of March 2021. That compares with $2.3M in the prior-year period — down 3.6% year over year. Use the charts on this page to explore GW Pharmaceuticals's other liabilities history and peer comparisons.

GW Pharmaceuticals's other liabilities decreased from $2.3M to $2.2M — a 3.6% year-over-year decrease (period ending March 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

GW Pharmaceuticals reported $2.2M in other liabilities as of March 2021. That compares with $2.3M in the prior-year period — down 3.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other liabilities of $2.2M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for GW Pharmaceuticals, and consider following GWPH for alerts when major investors trade the stock.

GW Pharmaceuticals is classified in the Healthcare sector. On other liabilities, it currently shows $2.2M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing GWPH with unrelated industries.